Filter announcements
Loading...
Ramky Infrastructure Limited is a flagship company of the Ramky Group. The Co is engaged in the business of construction, infrastructure development and management.
Ramky Infra reports Q1 FY25-26 results: Standalone Revenue 452 Cr, PAT 72 Cr, Nil Term Debt. Consolidated Revenue 471 Cr, PAT 39 Cr. Company boasts a 9,000 Cr standalone order book and 12,500 Cr consolidated order inflow, focusing on Industrial, Water, and Urban Solutions.
Ramky Infrastructure sold its 51% stake in subsidiary Visakha Pharmacity to Brij Gopal Construction Company for ₹165.24 Cr. This divestment of 91.80 lakh shares is not a related party transaction.
Ramky Infrastructure received the ET INFRA LEADERSHIP Award for "Excellence in Wastewater Management". The award recognizes its 2 MLD Legacy Leachate Treatment Facility in Jawahar Nagar, Hyderabad, India's largest and first of its kind, highlighting its technological leadership.
Ramky Infrastructure's Board addressed a penalty from the National Stock Exchange (NSE) due to compliance issues. The Board has instructed the Company Secretary to enhance technical care in future stock exchange filings. This emphasizes a focus on strengthening internal processes for regulatory adherence.
Ramky Infrastructure has exited its restructuring framework in July, with accounts now reclassified as Standard by lenders. This marks a significant operational shift. The company reported a strong Q1 FY25-26 performance with a robust order book of Rs 7,650 Cr. Standalone revenue reached Rs 354 Cr with a PAT of...